Timothy G. Youngquist 2020 Irrevocable Trust’s Context Therapeutics CNTX Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio CNTX Stock Details CNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$110K	Buy	+198,384	New	+$402K	0.02%	75

Other funds holding CNTX

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's CNTX Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust opened a new position in Context Therapeutics (CNTX) in Q2 2026: 198,384 shares worth $110K. The stake represents 0.02% of the portfolio and ranks #75 among its holdings.

75 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

Timothy G. Youngquist 2020 Irrevocable Trust held 198,384 shares of Context Therapeutics worth $110K as of Q2 2026.
Context Therapeutics was a new Timothy G. Youngquist 2020 Irrevocable Trust position in Q2 2026.
Context Therapeutics made up 0.02% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #75 holding.
75 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.